Skip to main content
. 2019 Jan 30;9(4):1115–1124. doi: 10.7150/thno.29622

Table 1.

EBV integrations detected in EBV-associated malignancies

No. of integration positive samples (total samples) Integration rate (95% confidence interval) Total No. of breakpoints detected No. of breakpoints per sample
Gastric carcinoma 10 (39) 25.6% (13.0 - 42.1%) 153 0 - 118
Hodgkin lymphoma 2 (11) 18.2% (2.3 - 51.8%) 8 0 - 5
NK/T cell lymphoma 4 (25) 16.0% (4.5 - 36.1%) 6 0 - 2
NPC 17 (177) 9.6% (5.7 - 14.9%) 28 0 - 6
Nasopharyngitis 0 (1)
C666-1 cell line 1 2